Apis Capital Advisors, LLC Buys Kemet Corp, Aerie Pharmaceuticals Inc, Dermira Inc, Sells Array BioPharma Inc, Intelsat SA, NovoCure

• New Purchases: AERI, DERM, INS, BOV, AXTI, HEAR, FRAN, FCSC,
• Added Positions: KEM, VICR, VKTX, LIQT,
• Reduced Positions: ARRY, I, NVCR, SIMO, GLNG, ZGNX, CYBE, GDOT, AMRN, MTCH, CBAY, DSPG, BSTC, SRPT, VRSK, GBT, TOCA,
• Sold Out: ESIO, APYX, CASM,

For the details of Apis Capital Advisors, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/apis+capital+advisors%2C+llc/current-portfolio/portfolio

1. Amarin Corp PLC (AMRN) - 1,126,700 shares, 28.21% of the total portfolio. Shares reduced by 3.04%
2. Array BioPharma Inc (ARRY) - 330,000 shares, 9.70% of the total portfolio. Shares reduced by 32.65%
3. Zogenix Inc (ZGNX) - 123,500 shares, 8.19% of the total portfolio. Shares reduced by 19.54%
4. Kemet Corp (KEM) - 340,000 shares, 6.96% of the total portfolio. Shares added by 61.90%
5. Golar LNG Ltd (GLNG) - 244,000 shares, 6.21% of the total portfolio. Shares reduced by 22.29%

Apis Capital Advisors, LLC initiated holding in Aerie Pharmaceuticals Inc. The purchase prices were between $36.1 and $49.25, with an estimated average price of $43.86. The stock is now traded at around $38.25. The impact to a portfolio due to this purchase was 1.72%. The holding were 30,000 shares as of .

Apis Capital Advisors, LLC initiated holding in Dermira Inc. The purchase prices were between $6.19 and $14.13, with an estimated average price of $8.29. The stock is now traded at around $10.50. The impact to a portfolio due to this purchase was 1.47%. The holding were 90,000 shares as of .

Apis Capital Advisors, LLC initiated holding in Intelligent Systems Corp. The purchase prices were between $12.92 and $33.3, with an estimated average price of $21.62. The stock is now traded at around $41.14. The impact to a portfolio due to this purchase was 0.77%. The holding were 20,000 shares as of .

Apis Capital Advisors, LLC initiated holding in Apyx Medical Corp. The purchase prices were between $5.35 and $7.75, with an estimated average price of $6.75. The stock is now traded at around $4.67. The impact to a portfolio due to this purchase was 0.53%. The holding were 70,000 shares as of .

Apis Capital Advisors, LLC initiated holding in AXT Inc. The purchase prices were between $3.9 and $4.6, with an estimated average price of $4.27. The stock is now traded at around $5.53. The impact to a portfolio due to this purchase was 0.38%. The holding were 70,000 shares as of .

Apis Capital Advisors, LLC initiated holding in Turtle Beach Corp. The purchase prices were between $10.73 and $17.81, with an estimated average price of $15.13. The stock is now traded at around $10.70. The impact to a portfolio due to this purchase was 0.27%. The holding were 20,000 shares as of .

Apis Capital Advisors, LLC added to a holding in Kemet Corp by 61.90%. The purchase prices were between $16.15 and $21.18, with an estimated average price of $18.4. The stock is now traded at around $17.76. The impact to a portfolio due to this purchase was 2.66%. The holding were 340,000 shares as of .

Apis Capital Advisors, LLC added to a holding in Viking Therapeutics Inc by 25.00%. The purchase prices were between $7.58 and $9.94, with an estimated average price of $8.38. The stock is now traded at around $8.33. The impact to a portfolio due to this purchase was 0.36%. The holding were 150,000 shares as of .

Apis Capital Advisors, LLC sold out a holding in Electro Scientific Industries Inc. The sale prices were between $29.91 and $30, with an estimated average price of $29.97.

Apis Capital Advisors, LLC sold out a holding in Apyx Medical Corp. The sale prices were between $6.31 and $8.75, with an estimated average price of $7.74.

Apis Capital Advisors, LLC sold out a holding in CAS Medical Systems Inc. The sale prices were between $1.57 and $2.47, with an estimated average price of $2.14.

Apis Capital Advisors, LLC reduced to a holding in Array BioPharma Inc by 32.65%. The sale prices were between $14.25 and $24.45, with an estimated average price of $20.7. The stock is now traded at around $22.37. The impact to a portfolio due to this sale was -3.06%. Apis Capital Advisors, LLC still held 330,000 shares as of .

Apis Capital Advisors, LLC reduced to a holding in Intelsat SA by 58.82%. The sale prices were between $15.2 and $24.9, with an estimated average price of $21.24. The stock is now traded at around $20.16. The impact to a portfolio due to this sale was -2.86%. Apis Capital Advisors, LLC still held 70,000 shares as of .

Apis Capital Advisors, LLC reduced to a holding in NovoCure Ltd by 68.68%. The sale prices were between $31.96 and $56.12, with an estimated average price of $47.95. The stock is now traded at around $47.62. The impact to a portfolio due to this sale was -2.5%. Apis Capital Advisors, LLC still held 25,400 shares as of .

Apis Capital Advisors, LLC reduced to a holding in Silicon Motion Technology Corp by 49.62%. The sale prices were between $33.13 and $43.89, with an estimated average price of $38.89. The stock is now traded at around $39.72. The impact to a portfolio due to this sale was -2.41%. Apis Capital Advisors, LLC still held 52,900 shares as of .

Apis Capital Advisors, LLC reduced to a holding in Golar LNG Ltd by 22.29%. The sale prices were between $20.6 and $24.38, with an estimated average price of $22.07. The stock is now traded at around $19.14. The impact to a portfolio due to this sale was -2.04%. Apis Capital Advisors, LLC still held 244,000 shares as of .

Apis Capital Advisors, LLC reduced to a holding in Match Group Inc by 28.57%. The sale prices were between $41.12 and $59.51, with an estimated average price of $52.75. The stock is now traded at around $60.37. The impact to a portfolio due to this sale was -0.57%. Apis Capital Advisors, LLC still held 25,000 shares as of .